JAPAN IP CATALYST
Emerging & Hybrid IPAI & Future

Regenerative Medicine (iPS Cells)

Popularity
개요

Japan's regenerative medicine research based on Professor Shinya Yamanaka's iPS cell technology. Since the 2012 Nobel Prize, clinical applications have steadily advanced. Japan leads the world in practical iPS cell treatments for retinal diseases, heart disease, and Parkinson's disease.

최종 수록일:편집: JAPAN IP CATALYST편집 방침출처: 하단 관련 링크 참조

※ 이 내용은 편집부 AI가 공개 정보를 바탕으로 생성한 아이디어입니다.

메타데이터
서브카테고리:AI & Future
소재지:Kyoto (Kyoto University)
시대:2006-present
영향 범위:세계
태그
iPS CellsRegenerative MedicineNobel Prize

Contemporary IPs

1986Dragon Ball (Anime)Content IP
1986The Legend of ZeldaContent IP
1986CastlevaniaContent IP
1986The Legend of ZeldaContent IP
1986Dragon QuestContent IP
1986Dragon QuestContent IP
1986Hideo KojimaContent IP
1986Nobuo UematsuContent IP
1986Maison IkkokuContent IP
1986Honda ASIMO RobotIndustrial & Brand IP
2006Regenerative Medicine (iPS Cells)Emerging & Hybrid IP

Recent News

Loading...

📱 Share on Social

Discovered: Regenerative Medicine (iPS Cells)!

Japan's regenerative medicine research based on Professor Shinya Yamanaka's iPS …

#iPSCells #RegenerativeMedicine #NobelPrize
#JAPANIPCATALYST #JapanCulture

Similar IPs